Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 16,260 shares at $174.87 ($2.9M) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Open-market sale of $2.9M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $174.87 | 374 | $65K | 2.3% |
| 2 | $174.87 | 374 | $65K | 2.3% |
| 3 | $175.95 | 1,139 | $200K | 6.9% |
| 4 | $175.95 | 1,139 | $200K | 6.9% |
| 5 | $177.00 | 2,200 | $389K | 13.5% |
| 6 | $177.87 | 4,747 |
| $844K |
| 29.3% |
| 7 | $177.87 | 4,747 | $844K | 29.3% |
| 8 | $178.80 | 1,540 | $275K | 9.5% |
| Total | $177.43 avg | 16,260 | $2.9M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |